![Richard Pulik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Pulik
Financieel Directeur/CFO bij ROIVANT SCIENCES LTD.
Vermogen: 3 M $ op 31-01-2025
Profiel
Momenteel bekleedt Richard Pulik de functie van Chief Financial Officer voor Roivant Sciences Ltd. en Chief Financial Officer voor Roivant Sciences, Inc. (een dochteronderneming van Roivant Sciences Ltd.). In het verleden was de heer Pulik Global Head-Business Development & Licensing bij Novartis Pharmaceuticals Corp. Hij behaalde een bachelordiploma aan de Universiteit van Pennsylvania en een bachelordiploma aan The Wharton School van de Universiteit van Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ROIVANT SCIENCES LTD.
0,04% | 28-01-2025 | 270 680 ( 0,04% ) | 3 M $ | 31-01-2025 |
Laatste nieuws over Richard Pulik
Actieve functies van Richard Pulik
| Bedrijven | Functie | Begin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Financieel Directeur/CFO | 28-09-2021 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Financieel Directeur/CFO | 28-09-2021 |
Eerdere bekende functies van Richard Pulik
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVARTIS AG | Investor Relations Contact | 01-08-2019 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Opleiding van Richard Pulik
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| NOVARTIS AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
